Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivudin ophthalmic solution vs aciclovir ointment in herpetic dendritic keratitis (Phase II)
2009-010971-26Phase 2Terminated
- Sponsor
- Menarini Group
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of brivudine in dendritic keratitis (2 arms), sponsored by Menarini Group. Primary endpoint: Time to healing of corneal lesions. Started Aug 2009; status: terminated.
02
Drugs
brivudine
03
Conditions
dendritic keratitis
Beyond the preview
Go deeper on 2009-010971-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010971-26.